| Accession Number | 0000943819-26-000016 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 11, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | ResMed Common Stock | โ | Mar 9, 2026 | Exercise/Conversion | 4,991 | $146.34 | $730,382.94 | 471,214 | Direct | โ | View Details | |
Director | ResMed Common Stock | โ | Mar 9, 2026 | Sale | 4,991 | $251.03 | $1,252,901.71 | 466,223 | Direct | โ | View Details | |
Director | ResMed Common Stock Options | Derivative | Mar 9, 2026 | Exercise/Conversion | 4,991 | $0.00 | $0.00 | 39,930 | Direct | โ | View Details |